|
21 |
EVALUATION OF WILD SUNFLOWER SPECIES FOR TOCOPHEROL CONTENT AND COMPOSITION/EVALUACIÓN DEL CONTENIDO Y COMPOSICIÓN DE TOCOFEROL EN LAS ESPECIES SILVESTRES DE GIRASOL/EVALUATION DE CONTENU ET COMPOSITION DE TOCOPHÉROL CHEZ LES ESPECES SAUVAGES DE TOURNESOL
Enthalten in Helia Bd. 27, 2004, Nr. 40: 107-112. 6 S.
|
|
|
|
22 |
DEVELOPMENT OF SUNFLOWER GERMPLASM WITH HIGH DELTA-TOCOPHEROL CONTENT/FORMACIÓN DE GERMOPLASMA DE GIRASOL CON ALTO CONTENIDO DE TOCOFEROL DELTA/FORMATION DE GERMES PLASMIQUES DE TOURNESOL D’UN CONTENU ÉLEVÉ DE DELTA-TOCOPHÉROL
Enthalten in Helia Bd. 27, 2004, Nr. 40: 99-106. 8 S.
|
|
|
|
23 |
IDENTIFICATION AND GENETIC CHARACTERIZATION OF NEW SOURCES OF BETAAND GAMMA-TOCOPHEROL IN SUNFLOWER GERMPLASM/IDENTIFICACIÓN Y CARACTERIZACIÓN GENÉTICA DE NUEVAS FUENTES DE BETA- Y GAMMA-TOCOFEROL EN GERMOPLASMA DE GIRASOL/IDENTIFICATION ET CARACTÉRISATION GÉNÉTIQUE DE NOUVELLES SOURCES BETA ET GAMMA DE TOCOPHÉROL DANS LE GERMOPLASME DU TOURNESOL
Enthalten in Helia Bd. 26, 2003, Nr. 38: 17-24. 8 S.
|
|
|
|
24 |
Association between biomarkers of iron status and cardiometabolic risk in Spanish children aged 9–10 years. The ELOIN study
Enthalten in Zeitschrift für Kinderheilkunde Bd. 182, 11.10.2023, Nr. 12, date:12.2023: 5649-5659
|
|
|
|
25 |
Author Correction: Combined quantification of procalcitonin and HLA-DR improves sepsis detection in surgical patients
Enthalten in Scientific reports Bd. 9, 27.2.2019, Nr. 1, date:12.2019: 1-2
|
|
|
|
26 |
Combined quantification of procalcitonin and HLA-DR improves sepsis detection in surgical patients
Enthalten in Scientific reports Bd. 8, 10.8.2018, Nr. 1, date:12.2018: 1-9
|
|
|
|
27 |
Correction to: Tissue-specific and repeat length-dependent somatic instability of the X-linked dystonia parkinsonism-associated CCCTCT repeat
Enthalten in Acta Neuropathologica Communications Bd. 10, 25.4.2022, Nr. 1, date:12.2022: 1
|
|
|
|
28 |
Evaluation of convalescent plasma versus standard of care for the treatment of COVID-19 in hospitalized patients: study protocol for a phase 2 randomized, open-label, controlled, multicenter trial
Enthalten in Trials Bd. 22, 20.1.2021, Nr. 1, date:12.2021: 1-14
|
|
|
|
29 |
Evaluation of the clinical use of MGMT methylation in extracellular vesicle-based liquid biopsy as a tool for glioblastoma patient management
Enthalten in Scientific reports Bd. 14, 18.5.2024, Nr. 1, date:12.2024: 1-13
|
|
|
|
30 |
Exome sequencing identifies a novel mutation in PIK3R1 as the cause of SHORT syndrome
Enthalten in BMC medical genetics Bd. 15, 2.5.2014, Nr. 1, date:12.2014: 1-6
|
|
Administration
